Cargando…
Case report: Serious unexpected vascular events in two patients with lymphocytic variant hypereosinophilic syndrome
BACKGROUND: Lymphocytic-variant hypereosinophilic syndrome (L-HES) is a form of reactive hypereosinophilia, most commonly associated with interleukin-5 over-production by clonal, most commonly CD3(−)CD4(+)CD2(hi)CD5(hi)CD45RO(+) T-cells. Patients often present with predominant cutaneous and soft-tis...
Autores principales: | Nathan, Torcida, Giulia, Casalino, Antoine, Bondue, Lise, Jodaitis, Frederic, Vanden Eynden, Florence, Roufosse |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565030/ https://www.ncbi.nlm.nih.gov/pubmed/37829688 http://dx.doi.org/10.3389/fcvm.2023.1256862 |
Ejemplares similares
-
Hypereosinophilic syndromes
por: Roufosse, Florence E, et al.
Publicado: (2007) -
Response to a case report: Idiopathic hypereosinophilic syndrome in remission with benralizumab treatment after relapse with mepolizumab
por: Requena, Gema, et al.
Publicado: (2021) -
Mepolizumab therapy improves the most bothersome symptoms in patients with hypereosinophilic syndrome
por: Roufosse, Florence, et al.
Publicado: (2023) -
Lung diffusion capacity correlates with pre‐implant pulmonary hypertension and predicts outcome after LVAD implantation
por: Macera, Francesca, et al.
Publicado: (2022) -
Hypereosinophilic syndrome complicated by severe vascular damage and gangrene
por: Gambichler, Thilo, et al.
Publicado: (2019)